Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HIV Exposure”

567 trials

Showing 20 of 567 results

Not applicableNot Yet RecruitingNCT06944691
What this trial is testing

Mental Health and PreP

Who this might be right for
Major Depressive Disorder in Patients Taking PrEP
Assistance Publique - Hôpitaux de Paris 600
Not applicableStudy completedNCT04621760
What this trial is testing

The OPENS Trial: Offering Women PrEP (Aim 1)

Who this might be right for
Human Immunodeficiency Virus TransmissionSexually Transmitted Diseases
University of California, San Francisco 189
Early research (Phase 1)Study completedNCT03293290
What this trial is testing

Project EMPOWERING: Evidence-based PrEP for Justice-Involved Women and Their Risk Networks

Who this might be right for
HIV Infections
Yale University 105
Not applicableStudy completedNCT05044286
What this trial is testing

Longer-Acting PrEP in Transgender and Gender Diverse Texans

Who this might be right for
HIV-1-infection
University of Texas at Austin 565
Post-approval studies (Phase 4)Study completedNCT01214759
What this trial is testing

Truvada Plus Raltegravir for Nonoccupational Post-exposure Prophylaxis (nPEP)

Who this might be right for
HIV
The University of Texas Health Science Center, Houston 103
Large-scale testing (Phase 3)Study completedNCT01146873
What this trial is testing

Treatment Options for Protease Inhibitor-exposed Children

Who this might be right for
HIV/AIDSHIV Infections
Columbia University 300
Not applicableLooking for participantsNCT07497594
What this trial is testing

ImPrEP LEN Brasil: Twice-Yearly Lenacapavir for HIV Prevention

Who this might be right for
Contact With or Exposure to Human Immunodeficiency Virus
Oswaldo Cruz Foundation 1,500
Not applicableStudy completedNCT02367807
What this trial is testing

PrEP With TDF/FTC to Prevent HIV-1 Acquisition in Young MSM and Transgender Women of Color

Who this might be right for
HIV
Philadelphia Fight 50
Not applicableStudy completedNCT05991869
What this trial is testing

Leveraging Electronic Health Record Data in a Risk Prediction Model to Increase HIV PrEP Intake in Primary Care

Who this might be right for
Pre-Exposure Prophylaxis
Kaiser Permanente 121
Not applicableStudy completedNCT04038060
What this trial is testing

The PrEP (Pre-exposure Prophylaxis) SMART Study

Who this might be right for
HIV/AIDS
University of Washington 360
Not applicableStudy completedNCT03098693
What this trial is testing

Dyadic-Based Diagnosis, Care, and Prevention for HIV Discordant Couples in Tanzania

Who this might be right for
HIV
Medical University of South Carolina 128
Not applicableUnknownNCT03436407
What this trial is testing

Evaluation of Implementation of Pre-exposure Prophylaxis (PrEP) in Norway

Who this might be right for
HivSexually Transmitted DiseasesMental Health Wellness 1
Oslo University Hospital 500
Not applicableStudy completedNCT03459157
What this trial is testing

Access to PrEP for MSM: Acceptability and Feasibility in Community-based Clinics in West Africa (CohMSM-PrEP)

Who this might be right for
HIV/AIDS
ANRS, Emerging Infectious Diseases 649
Large-scale testing (Phase 3)Looking for participantsNCT07047716
What this trial is testing

Study of Lenacapavir as a Once-Yearly Injection for HIV Pre-exposure Prophylaxis (PrEP)

Who this might be right for
HIV Pre-exposure Prophylaxis
Gilead Sciences 350
Post-approval studies (Phase 4)Study completedNCT01576731
What this trial is testing

Study Comparing Two Alternatives of Antiretroviral Therapy as Post-exposure Prophylaxis to HIV-1: Tenofovir + Emtricitabine + Lopinavir/Ritonavir Versus Tenofovir + Emtricitabine + Raltegravir (RAL-PEP)

Who this might be right for
HIV Infection
Hospital Clinic of Barcelona 240
Not applicableStudy completedNCT04048551
What this trial is testing

The PrEPARE Project: Prevention, Empowering, and Protecting Young Women in South Africa

Who this might be right for
HIV Prevention
RTI International 802
Post-approval studies (Phase 4)Study completedNCT04233372
What this trial is testing

Evaluation of (Doravirine / Lamivudine / Tenofovir Disoproxil Fumarate) (Delstrigo®) as a New Strategy for Non-occupational Post Exposure Prophylaxis, a Prospective Open Label Study

Who this might be right for
Hiv
Hospital Clinic of Barcelona 399
Not applicableNot Yet RecruitingNCT06316089
What this trial is testing

An Intervention to Improve HIV Pre-exposure Prophylaxis Initiation, Adherence and Linkage to Care for Recently Incarcerated Men Who Inject Drugs.

Who this might be right for
HivSubstance Use Disorders
Rhode Island Hospital 100
Not applicableStudy completedNCT04030520
What this trial is testing

Improving Uptake and Adherence to HIV Prevention Services With Pre-exposure Prophylaxis (PrEP), HIV Self- Testing and Adherence Support for Very High Risk HIV-negative Young Women Aged 15-24 in Kampala, Uganda

Who this might be right for
HIV/AIDS
University of California, San Francisco 60
Not applicableStudy completedNCT03030768
What this trial is testing

Safer Conception Intervention for HIV-1 Serodiscordant Couples

Who this might be right for
HIV SeropositivityPregnancy, High-Risk
University of Washington 74
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation